Variation in Medicaid and commercial coverage of cell and gene therapies.

Beinfeld, Molly T; Rucker, Julia A; Jenkins, Nola B; de Breed, Lucas A; Chambers, James D

Beinfeld, Molly T; Rucker, Julia A; Jenkins, Nola B; de Breed, Lucas A; Chambers, James D.

Afiliación

Beinfeld MT; Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, Boston, MA, United States.
Rucker JA; Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, Boston, MA, United States.
Jenkins NB; Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, Boston, MA, United States.
de Breed LA; August, LLC, NY, New York.
Chambers JD; Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, Boston, MA, United States.

Health Policy Open ; 5: 100103, 2023 Dec 15.

Article en En | MEDLINE | ID: mdl-38023441

Palabras clave

Genetic therapy; Health care economics; Health policy; Insurance; Medicaid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Health Policy Open Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos